Early 5-aminosalicylate use in pediatric Crohn disease is linked to reduced durability of future biologic therapy and higher corticosteroid exposure.
Among adults with T2D and high BP, an intervention of MTM was effective for improing diet quality, even with gradual down dosing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results